These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15265773)

  • 1. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.
    Sengupta S; Wasylyk B
    Ann N Y Acad Sci; 2004 Jun; 1024():54-71. PubMed ID: 15265773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid and sex hormone receptors: clinical implications and therapeutic relevance.
    Stefanaki C; Chrousos GP; Katsambas A
    Dermatol Clin; 2007 Oct; 25(4):503-13, viii. PubMed ID: 17903609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of prostate cancer cell survival after inhibition of AR expression.
    Cohen MB; Rokhlin OW
    J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of histone deacetylase inhibitors on glucocorticoid and estrogen signaling in human endometrial Ishikawa cells.
    Rocha W; Sanchez R; Deschênes J; Auger A; Hébert E; White JH; Mader S
    Mol Pharmacol; 2005 Dec; 68(6):1852-62. PubMed ID: 16186250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor activity is inhibited in response to genotoxic agents in a p53-independent manner.
    Mantoni TS; Reid G; Garrett MD
    Oncogene; 2006 May; 25(22):3139-49. PubMed ID: 16434973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.
    Chebotaev D; Yemelyanov A; Budunova I
    Mol Carcinog; 2007 Aug; 46(8):732-40. PubMed ID: 17538956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
    Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
    Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
    Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
    J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and its downstream proteins as molecular targets of cancer.
    Sun Y
    Mol Carcinog; 2006 Jun; 45(6):409-15. PubMed ID: 16652354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of nuclear sex hormone receptors in gene regulation.
    Kato S; Sato T; Watanabe T; Takemasa S; Masuhiro Y; Ohtake F; Matsumoto T
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():4-9. PubMed ID: 16273365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
    Smith RA; Lea RA; Weinstein SR; Griffiths LR
    Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response.
    Verrijdt G; Tanner T; Moehren U; Callewaert L; Haelens A; Claessens F
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1089-94. PubMed ID: 17073757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
    Yan TZ; Jin FS; Xie LP; Li LC
    Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of steroids in mitochondria.
    Gavrilova-Jordan LP; Price TM
    Semin Reprod Med; 2007 May; 25(3):154-64. PubMed ID: 17447205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p53 in apoptosis.
    Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
    Discov Med; 2010 Feb; 9(45):145-52. PubMed ID: 20193641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
    Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
    IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.
    Sun C; Shi Y; Xu LL; Nageswararao C; Davis LD; Segawa T; Dobi A; McLeod DG; Srivastava S
    Oncogene; 2006 Jun; 25(28):3905-13. PubMed ID: 16636679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.